VERSATOPE THERAPEUTICS, INC. SBIR Phase I Award, September 2019
A SBIR Phase I contract was awarded to Versatope Therapeutics in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.
Currently, there are no issues on this topic.
Find more entities like VERSATOPE THERAPEUTICS, INC. SBIR Phase I Award, September 2019
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.